Home > News > Webcast of Conference Call to Discuss NUCRYST Pharmaceuticals' results
September 7th, 2004
Webcast of Conference Call to Discuss NUCRYST Pharmaceuticals' results
Abstract:
The Westaim Corporation will hold a webcast at 9:00 a.m. EDT on Wednesday September 8, 2004 regarding
NUCRYST Pharmaceuticals' results of its first Phase 2a human clinical trial. The investigational drug (NPI 32101) is being studied for atopic dermatitis, a form of eczema, and represents a biological application of nanotechnology.
Source:
PRNewswire
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||